janasiebenlist.bsky.social
@janasiebenlist.bsky.social
Reposted
Very excited to see this out and happy to have contributed!
How to disconnect therapy-resistant tumor networks in glioblastoma?

In our paper, online @Cancer Discovery, we built an anti-tumor microtube (TM) screening pipeline and found that Protein Kinase C activators disrupt TMs, silence Ca²⁺ “pacemakers” and boost radiotherapy.
doi.org/10.1158/2159...
October 10, 2025 at 7:35 AM
Reposted
Exploration of oncogenic cooperation between germline variation and somatic mutation in #prostate cancer progression

www.biorxiv.org/content/10.1...
Exploration of oncogenic cooperation between germline variation and somatic mutation in prostate cancer progression
Prostate carcinoma (PCa) is the most common cancer of men, associated with a still unresolved issue of accurate risk-stratification. While recent advances in omics technologies have provided clues as ...
www.biorxiv.org
August 7, 2025 at 1:55 PM
Reposted
Very proud on our stellar Alina Ritter for her frist first-author paper:

Targeting CXADR-mediated AKT signaling suppresses tumorigenesis and enhances #chemotherapy efficacy in #Ewing #sarcoma

tinyurl.com/3kcs3bc9

@dkfz.bsky.social
@uniheidelberg.bsky.social
@nct-heidelberg.bsky.social
August 11, 2025 at 6:38 AM